Please use this identifier to cite or link to this item:
Title: Serotonergic and dopaminergic systems in anorexia nervosa: a role for atypical antipsychotics?
Austin Authors: Bosanac, Peter;Norman, Trevor R ;Burrows, Graham D;Beumont, Peter
Affiliation: Austin Health and Department of Psychiatry, The University of Melbourne, Austin Hospital, Austin Health, Victoria, Australia
Issue Date: 1-Mar-2005
Publication information: The Australian and New Zealand Journal of Psychiatry; 39(3): 146-53
Abstract: To review serotonergic and dopaminergic system function in anorexia nervosa in terms of potential modulation by atypical antipsychotic medications.A systematic review of clinical, neurobiological and functional neuroimaging findings of serotonergic and dopaminergic system activity in anorexia nervosa was conducted via MEDLINE, PsycINFO and EMBASE psychiatry databases, with a critical review of dysregulation of these systems as therapeutic targets for atypical antipsychotics, in context of evidence regarding the utility and efficacy of these medications in this syndrome.There is evidence of persistently altered serotonergic and dopaminergic function in anorexia nervosa independent to weight-recovery. Case reports, open-label and single-blinded studies, albeit sparse, suggest that atypical antipsychotics may be beneficial in the management of anorexia nervosa psychopathology beyond weight gain.Double-blind placebo controlled studies of atypical antipsychotics in anorexia nervosa with well defined outcome measures are required.
Gov't Doc #: 15701063
DOI: 10.1111/j.1440-1614.2005.01536.x
Type: Journal Article
Subjects: Anorexia Nervosa.drug therapy.physiopathology
Antipsychotic Agents.therapeutic use
Brain.drug effects.physiopathology
Randomized Controlled Trials as Topic
Treatment Outcome
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Nov 29, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.